Vitrakvi was approved by the FDA last November for patients with advanced solid tumours with an NTRK gene fusion, and filings in Europe and other markets are in play. Follow-up LOXO-195 – now re ...
During a Community Case Forum event in partnership with the Texas Society of Clinical Oncology, Natalie Vokes, MD, discussed ...
Rodabe Amaria, MD, discusses the current role of OBX-115 for the treatment of patients with checkpoint inhibitor-resistant metastatic melanoma. Rodabe Amaria, MD, medical oncologist in the Department ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback